Kalliopi Zachou

Larisa, ESYE14, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.

HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.

Journal: Journal of viral hepatitis

Published: February 23, 2026

Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment.

Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 11, 2026

Cell-specific epigenome-wide DNA methylation in peripheral CD4(+) lymphocytes from patients with primary biliary cholangitis.

Cell-specific epigenome-wide DNA methylation in peripheral CD4(+) lymphocytes from patients with primary biliary cholangitis.

Journal: Journal of translational autoimmunity

Published: June 15, 2025

Complementary use of autoantibody detection methods facilitates diagnosis of juvenile autoimmune hepatitis and autoimmune sclerosing cholangitis.

Complementary use of autoantibody detection methods facilitates diagnosis of juvenile autoimmune hepatitis and autoimmune sclerosing cholangitis.

Journal: JHEP reports : innovation in hepatology

Published: March 24, 2025

HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D.

HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 09, 2025

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy.

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 17, 2025

Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis.

Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 17, 2024

Effective Management of Life-Threatening Generalized Pustular Psoriasis Flare With Spesolimab.

Effective Management of Life-Threatening Generalized Pustular Psoriasis Flare With Spesolimab.

Journal: Cureus

Published: July 13, 2024

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma.

Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma.

Journal: Annals of hepatology

Published: May 09, 2024

Efficacy and safety of infliximab in patients with autoimmune hepatitis.

Efficacy and safety of infliximab in patients with autoimmune hepatitis.

Journal: Hepatology (Baltimore, Md.)

Published: May 08, 2024

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.

Journal: JHEP reports : innovation in hepatology

Published: May 03, 2024

PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality.

PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality.

Journal: Journal of translational autoimmunity

Published: April 27, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026